1 Study Coverage 1.1 Anti-Malarial Drug Product Introduction 1.2 Market by Type 1.2.1 Global Anti-Malarial Drug Market Size Growth Rate by Type 1.4.2 Plasmodium Falciparum 1.4.3 Plasmodium Vivax 1.2.4 Plasmodium Malariae 1.2.5 Plasmodium Ovale 1.3 Market by Application 1.3.1 Global Anti-Malarial Drug Market Size Growth Rate by Application 1.3.2 Hospital Pharmacy 1.3.3 Retail Pharmacy 1.3.4 E-Commerce 1.3.5 Others 1.4 Study Objectives 1.5 Years Considered 2 Executive Summary 2.1 Global Anti-Malarial Drug Sales Estimates and Forecasts 2016-2027 2.2 Global Anti-Malarial Drug Revenue Estimates and Forecasts 2016-2027 2.3 Global Anti-Malarial Drug Revenue by Region: 2016 VS 2021 VS 2027 2.4 Global Top Anti-Malarial Drug Regions by Sales 2.4.1 Global Top Anti-Malarial Drug Regions by Sales (2016-2021) 2.4.2 Global Top Anti-Malarial Drug Regions by Sales (2022-2027) 2.5 Global Top Anti-Malarial Drug Regions by Revenue 2.5.1 Global Top Anti-Malarial Drug Regions by Revenue (2016-2021) 2.5.2 Global Top Anti-Malarial Drug Regions by Revenue (2022-2027) 2.6 North America 2.7 Europe 2.8 Asia-Pacific 2.9 Latin America 2.10 Middle East & Africa 3 Competition by Manufacturers 3.1 Global Anti-Malarial Drug Sales by Manufacturers 3.1.1 Global Top Anti-Malarial Drug Manufacturers by Sales (2016-2021) 3.1.2 Global Top Anti-Malarial Drug Manufacturers Market Share by Sales (2016-2021) 3.1.3 Global Top 10 and Top 5 Companies by Anti-Malarial Drug Sales in 2020 3.2 Global Anti-Malarial Drug Revenue by Manufacturers 3.2.1 Global Top Anti-Malarial Drug Manufacturers by Revenue (2016-2021) 3.2.2 Global Top Anti-Malarial Drug Manufacturers Market Share by Revenue (2016-2021) 3.2.3 Global Top 10 and Top 5 Companies by Anti-Malarial Drug Revenue in 2020 3.3 Global Anti-Malarial Drug Sales Price by Manufacturers 3.4 Analysis of Competitive Landscape 3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Anti-Malarial Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.4.3 Global Anti-Malarial Drug Manufacturers Geographical Distribution 3.5 Mergers & Acquisitions, Expansion Plans 4 Market Size by Type 4.1 Global Anti-Malarial Drug Sales by Type 4.1.1 Global Anti-Malarial Drug Historical Sales by Type (2016-2021) 4.1.2 Global Anti-Malarial Drug Forecasted Sales by Type (2022-2027) 4.1.3 Global Anti-Malarial Drug Sales Market Share by Type (2016-2027) 4.2 Global Anti-Malarial Drug Revenue by Type 4.2.1 Global Anti-Malarial Drug Historical Revenue by Type (2016-2021) 4.2.2 Global Anti-Malarial Drug Forecasted Revenue by Type (2022-2027) 4.2.3 Global Anti-Malarial Drug Revenue Market Share by Type (2016-2027) 4.3 Global Anti-Malarial Drug Price by Type 4.3.1 Global Anti-Malarial Drug Price by Type (2016-2021) 4.3.2 Global Anti-Malarial Drug Price Forecast by Type (2022-2027) 5 Market Size by Application 5.1 Global Anti-Malarial Drug Sales by Application 5.1.1 Global Anti-Malarial Drug Historical Sales by Application (2016-2021) 5.1.2 Global Anti-Malarial Drug Forecasted Sales by Application (2022-2027) 5.1.3 Global Anti-Malarial Drug Sales Market Share by Application (2016-2027) 5.2 Global Anti-Malarial Drug Revenue by Application 5.2.1 Global Anti-Malarial Drug Historical Revenue by Application (2016-2021) 5.2.2 Global Anti-Malarial Drug Forecasted Revenue by Application (2022-2027) 5.2.3 Global Anti-Malarial Drug Revenue Market Share by Application (2016-2027) 5.3 Global Anti-Malarial Drug Price by Application 5.3.1 Global Anti-Malarial Drug Price by Application (2016-2021) 5.3.2 Global Anti-Malarial Drug Price Forecast by Application (2022-2027) 6 North America 6.1 North America Anti-Malarial Drug Market Size by Type 6.1.1 North America Anti-Malarial Drug Sales by Type (2016-2027) 6.1.2 North America Anti-Malarial Drug Revenue by Type (2016-2027) 6.2 North America Anti-Malarial Drug Market Size by Application 6.2.1 North America Anti-Malarial Drug Sales by Application (2016-2027) 6.2.2 North America Anti-Malarial Drug Revenue by Application (2016-2027) 6.3 North America Anti-Malarial Drug Market Size by Country 6.3.1 North America Anti-Malarial Drug Sales by Country (2016-2027) 6.3.2 North America Anti-Malarial Drug Revenue by Country (2016-2027) 6.3.3 U.S. 6.3.4 Canada 7 Europe 7.1 Europe Anti-Malarial Drug Market Size by Type 7.1.1 Europe Anti-Malarial Drug Sales by Type (2017-2027) 7.1.2 Europe Anti-Malarial Drug Revenue by Type (2017-2027) 7.2 Europe Anti-Malarial Drug Market Size by Application 7.2.1 Europe Anti-Malarial Drug Sales by Application (2017-2027) 7.2.2 Europe Anti-Malarial Drug Revenue by Application (2017-2027) 7.3 Europe Anti-Malarial Drug Market Size by Country 7.3.1 Europe Anti-Malarial Drug Sales by Country (2017-2027) 7.3.2 Europe Anti-Malarial Drug Revenue by Country (2017-2027) 7.3.3 Germany 7.3.4 France 7.3.5 U.K. 7.3.6 Italy 7.3.7 Russia 8 Asia Pacific 8.1 Asia Pacific Anti-Malarial Drug Market Size by Type 8.1.1 Asia Pacific Anti-Malarial Drug Sales by Type (2018-2027) 8.1.2 Asia Pacific Anti-Malarial Drug Revenue by Type (2018-2027) 8.2 Asia Pacific Anti-Malarial Drug Market Size by Application 8.2.1 Asia Pacific Anti-Malarial Drug Sales by Application (2018-2027) 8.2.2 Asia Pacific Anti-Malarial Drug Revenue by Application (2018-2027) 8.3 Asia Pacific Anti-Malarial Drug Market Size by Region 8.3.1 Asia Pacific Anti-Malarial Drug Sales by Region (2018-2027) 8.3.2 Asia Pacific Anti-Malarial Drug Revenue by Region (2018-2027) 8.3.3 China 8.3.4 Japan 8.3.5 South Korea 8.3.6 India 8.3.7 Australia 8.3.8 Taiwan 8.3.9 Indonesia 8.3.10 Thailand 8.3.11 Malaysia 8.3.12 Philippines 9 Latin America 9.1 Latin America Anti-Malarial Drug Market Size by Type 9.1.1 Latin America Anti-Malarial Drug Sales by Type (2019-2027) 9.1.2 Latin America Anti-Malarial Drug Revenue by Type (2019-2027) 9.2 Latin America Anti-Malarial Drug Market Size by Application 9.2.1 Latin America Anti-Malarial Drug Sales by Application (2019-2027) 9.2.2 Latin America Anti-Malarial Drug Revenue by Application (2019-2027) 9.3 Latin America Anti-Malarial Drug Market Size by Country 9.3.1 Latin America Anti-Malarial Drug Sales by Country (2019-2027) 9.3.2 Latin America Anti-Malarial Drug Revenue by Country (2019-2027) 9.3.3 Mexico 9.3.4 Brazil 9.3.5 Argentina 6 Middle East and Africa 6.1 Middle East and Africa Anti-Malarial Drug Market Size by Type 6.1.1 Middle East and Africa Anti-Malarial Drug Sales by Type (2016-2027) 6.1.2 Middle East and Africa Anti-Malarial Drug Revenue by Type (2016-2027) 6.2 Middle East and Africa Anti-Malarial Drug Market Size by Application 6.2.1 Middle East and Africa Anti-Malarial Drug Sales by Application (2016-2027) 6.2.2 Middle East and Africa Anti-Malarial Drug Revenue by Application (2016-2027) 6.3 Middle East and Africa Anti-Malarial Drug Market Size by Country 6.3.1 Middle East and Africa Anti-Malarial Drug Sales by Country (2016-2027) 6.3.2 Middle East and Africa Anti-Malarial Drug Revenue by Country (2016-2027) 6.3.3 Turkey 6.3.4 Saudi Arabia 6.3.5 U.A.E 11 Company Profiles 11.1 GlaxoSmithKline 11.1.1 GlaxoSmithKline Corporation Information 11.1.2 GlaxoSmithKline Overview 11.1.3 GlaxoSmithKline Anti-Malarial Drug Sales, Price, Revenue and Gross Margin (2016-2021) 11.1.4 GlaxoSmithKline Anti-Malarial Drug Product Description 11.1.5 GlaxoSmithKline Related Developments 11.2 Ranbaxy 11.2.1 Ranbaxy Corporation Information 11.2.2 Ranbaxy Overview 11.2.3 Ranbaxy Anti-Malarial Drug Sales, Price, Revenue and Gross Margin (2016-2021) 11.2.4 Ranbaxy Anti-Malarial Drug Product Description 11.2.5 Ranbaxy Related Developments 11.3 Zydus Cadila 11.3.1 Zydus Cadila Corporation Information 11.3.2 Zydus Cadila Overview 11.3.3 Zydus Cadila Anti-Malarial Drug Sales, Price, Revenue and Gross Margin (2016-2021) 11.3.4 Zydus Cadila Anti-Malarial Drug Product Description 11.3.5 Zydus Cadila Related Developments 11.4 Alvizia 11.4.1 Alvizia Corporation Information 11.4.2 Alvizia Overview 11.4.3 Alvizia Anti-Malarial Drug Sales, Price, Revenue and Gross Margin (2016-2021) 11.4.4 Alvizia Anti-Malarial Drug Product Description 11.4.5 Alvizia Related Developments 11.5 Bayer 11.5.1 Bayer Corporation Information 11.5.2 Bayer Overview 11.5.3 Bayer Anti-Malarial Drug Sales, Price, Revenue and Gross Margin (2016-2021) 11.5.4 Bayer Anti-Malarial Drug Product Description 11.5.5 Bayer Related Developments 11.6 Ipca 11.6.1 Ipca Corporation Information 11.6.2 Ipca Overview 11.6.3 Ipca Anti-Malarial Drug Sales, Price, Revenue and Gross Margin (2016-2021) 11.6.4 Ipca Anti-Malarial Drug Product Description 11.6.5 Ipca Related Developments 11.7 Merck 11.7.1 Merck Corporation Information 11.7.2 Merck Overview 11.7.3 Merck Anti-Malarial Drug Sales, Price, Revenue and Gross Margin (2016-2021) 11.7.4 Merck Anti-Malarial Drug Product Description 11.7.5 Merck Related Developments 11.8 F. Hoffmann-La Roche 11.8.1 F. Hoffmann-La Roche Corporation Information 11.8.2 F. Hoffmann-La Roche Overview 11.8.3 F. Hoffmann-La Roche Anti-Malarial Drug Sales, Price, Revenue and Gross Margin (2016-2021) 11.8.4 F. Hoffmann-La Roche Anti-Malarial Drug Product Description 11.8.5 F. Hoffmann-La Roche Related Developments 11.9 Novartis 11.9.1 Novartis Corporation Information 11.9.2 Novartis Overview 11.9.3 Novartis Anti-Malarial Drug Sales, Price, Revenue and Gross Margin (2016-2021) 11.9.4 Novartis Anti-Malarial Drug Product Description 11.9.5 Novartis Related Developments 11.10 Pfizer 11.10.1 Pfizer Corporation Information 11.10.2 Pfizer Overview 11.10.3 Pfizer Anti-Malarial Drug Sales, Price, Revenue and Gross Margin (2016-2021) 11.10.4 Pfizer Anti-Malarial Drug Product Description 11.10.5 Pfizer Related Developments 11.1 GlaxoSmithKline 11.1.1 GlaxoSmithKline Corporation Information 11.1.2 GlaxoSmithKline Overview 11.1.3 GlaxoSmithKline Anti-Malarial Drug Sales, Price, Revenue and Gross Margin (2016-2021) 11.1.4 GlaxoSmithKline Anti-Malarial Drug Product Description 11.1.5 GlaxoSmithKline Related Developments 12 Value Chain and Sales Channels Analysis 12.1 Anti-Malarial Drug Value Chain Analysis 12.2 Anti-Malarial Drug Key Raw Materials 12.2.1 Key Raw Materials 12.2.2 Raw Materials Key Suppliers 12.3 Anti-Malarial Drug Production Mode & Process 12.4 Anti-Malarial Drug Sales and Marketing 12.4.1 Anti-Malarial Drug Sales Channels 12.4.2 Anti-Malarial Drug Distributors 12.5 Anti-Malarial Drug Customers 13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis 13.1 Anti-Malarial Drug Industry Trends 13.2 Anti-Malarial Drug Market Drivers 13.3 Anti-Malarial Drug Market Challenges 13.4 Anti-Malarial Drug Market Restraints 14 Key Findings in The Global Anti-Malarial Drug Study 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Author Details 15.3 Disclaimer

List of Tables Table 1. Global Anti-Malarial Drug Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million) Table 2. Major Manufacturers of Plasmodium Falciparum Table 3. Major Manufacturers of Plasmodium Vivax Table 4. Major Manufacturers of Plasmodium Malariae Table 5. Major Manufacturers of Plasmodium Ovale Table 6. Global Anti-Malarial Drug Market Size Growth Rate by Application, 2016 VS 2021 VS 2027 (US$ Million) Table 7. Global Anti-Malarial Drug Revenue by Region: 2016 VS 2021 VS 2027 (US$ Million) Table 8. Global Anti-Malarial Drug Sales by Region (2016-2021) & (MT) Table 9. Global Anti-Malarial Drug Sales Market Share by Region (2016-2021) Table 10. Global Anti-Malarial Drug Sales by Region (2016-2021) & (MT) Table 11. Global Anti-Malarial Drug Sales Market Share by Region (2022-2027) Table 12. Global Anti-Malarial Drug Revenue by Region (2016-2021) & (US$ Million) Table 13. Global Anti-Malarial Drug Revenue Market Share by Region (2016-2021) Table 14. Global Anti-Malarial Drug Revenue by Region (2022-2027) & (US$ Million) Table 15. Global Anti-Malarial Drug Revenue Market Share by Region (2022-2027) Table 16. Global Anti-Malarial Drug Sales by Manufacturers (2016-2021) & (MT) Table 17. Global Anti-Malarial Drug Sales Share by Manufacturers (2016-2021) Table 18. Global Anti-Malarial Drug Revenue by Manufacturers (2016-2021) & (US$ Million) Table 19. Global Anti-Malarial Drug Revenue Share by Manufacturers (2016-2021) Table 20. Anti-Malarial Drug Price by Manufacturers 2016-2021 (USD/Kg) Table 21. Global Anti-Malarial Drug Manufacturers Market Concentration Ratio (CR5 and HHI) Table 22. Global Anti-Malarial Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-Malarial Drug as of 2020) Table 23. Anti-Malarial Drug Manufacturing Base Distribution and Headquarters Table 24. Manufacturers Anti-Malarial Drug Product Offered Table 25. Date of Manufacturers Enter into Anti-Malarial Drug Market Table 26. Mergers & Acquisitions, Expansion Plans Table 27. Global Anti-Malarial Drug Sales by Type (2016-2021) & (MT) Table 28. Global Anti-Malarial Drug Sales by Type (2022-2027) & (MT) Table 29. Global Anti-Malarial Drug Sales Share by Type (2016-2021) Table 30. Global Anti-Malarial Drug Sales Share by Type (2022-2027) Table 31. Global Anti-Malarial Drug Revenue by Type (2016-2021) & (US$ Million) Table 32. Global Anti-Malarial Drug Revenue by Type (2022-2027) & (US$ Million) Table 33. Global Anti-Malarial Drug Revenue Share by Type (2016-2021) Table 34. Global Anti-Malarial Drug Revenue Share by Type (2022-2027) Table 35. Anti-Malarial Drug Price by Type (2016-2021) & (USD/Kg) Table 36. Global Anti-Malarial Drug Price Forecast by Type (2022-2027) & (USD/Kg) Table 37. Global Anti-Malarial Drug Sales by Application (2016-2021) & (MT) Table 38. Global Anti-Malarial Drug Sales by Application (2022-2027) & (MT) Table 39. Global Anti-Malarial Drug Sales Share by Application (2016-2021) Table 40. Global Anti-Malarial Drug Sales Share by Application (2022-2027) Table 41. Global Anti-Malarial Drug Revenue by Application (2016-2021) & (US$ Million) Table 42. Global Anti-Malarial Drug Revenue by Application (2022-2027) & (US$ Million) Table 43. Global Anti-Malarial Drug Revenue Share by Application (2016-2021) Table 44. Global Anti-Malarial Drug Revenue Share by Application (2022-2027) Table 45. Anti-Malarial Drug Price by Application (2016-2021) & (USD/Kg) Table 46. Global Anti-Malarial Drug Price Forecast by Application (2022-2027) & (USD/Kg) Table 47. North America Anti-Malarial Drug Sales by Type (2016-2021) & (MT) Table 48. North America Anti-Malarial Drug Sales by Type (2022-2027) & (MT) Table 49. North America Anti-Malarial Drug Revenue by Type (2016-2021) & (US$ Million) Table 50. North America Anti-Malarial Drug Revenue by Type (2022-2027) & (US$ Million) Table 51. North America Anti-Malarial Drug Sales by Application (2016-2021) & (MT) Table 52. North America Anti-Malarial Drug Sales by Application (2022-2027) & (MT) Table 53. North America Anti-Malarial Drug Revenue by Application (2016-2021) & (US$ Million) Table 54. North America Anti-Malarial Drug Revenue by Application (2022-2027) & (US$ Million) Table 55. North America Anti-Malarial Drug Sales by Country (2016-2021) & (MT) Table 56. North America Anti-Malarial Drug Sales by Country (2022-2027) & (MT) Table 57. North America Anti-Malarial Drug Revenue by Country (2016-2021) & (US$ Million) Table 58. North America Anti-Malarial Drug Revenue by Country (2022-2027) & (US$ Million) Table 59. Europe Anti-Malarial Drug Sales by Type (2016-2021) & (MT) Table 60. Europe Anti-Malarial Drug Sales by Type (2022-2027) & (MT) Table 61. Europe Anti-Malarial Drug Revenue by Type (2016-2021) & (US$ Million) Table 62. Europe Anti-Malarial Drug Revenue by Type (2022-2027) & (US$ Million) Table 63. Europe Anti-Malarial Drug Sales by Application (2016-2021) & (MT) Table 64. Europe Anti-Malarial Drug Sales by Application (2022-2027) & (MT) Table 65. Europe Anti-Malarial Drug Revenue by Application (2016-2021) & (US$ Million) Table 66. Europe Anti-Malarial Drug Revenue by Application (2022-2027) & (US$ Million) Table 67. Europe Anti-Malarial Drug Sales by Country (2016-2021) & (MT) Table 68. Europe Anti-Malarial Drug Sales by Country (2022-2027) & (MT) Table 69. Europe Anti-Malarial Drug Revenue by Country (2016-2021) & (US$ Million) Table 70. Europe Anti-Malarial Drug Revenue by Country (2022-2027) & (US$ Million) Table 71. Asia Pacific Anti-Malarial Drug Sales by Type (2016-2021) & (MT) Table 72. Asia Pacific Anti-Malarial Drug Sales by Type (2022-2027) & (MT) Table 73. Asia Pacific Anti-Malarial Drug Revenue by Type (2016-2021) & (US$ Million) Table 74. Asia Pacific Anti-Malarial Drug Revenue by Type (2022-2027) & (US$ Million) Table 75. Asia Pacific Anti-Malarial Drug Sales by Application (2016-2021) & (MT) Table 76. Asia Pacific Anti-Malarial Drug Sales by Application (2022-2027) & (MT) Table 77. Asia Pacific Anti-Malarial Drug Revenue by Application (2016-2021) & (US$ Million) Table 78. Asia Pacific Anti-Malarial Drug Revenue by Application (2022-2027) & (US$ Million) Table 79. Asia Pacific Anti-Malarial Drug Sales by Region (2016-2021) & (MT) Table 80. Asia Pacific Anti-Malarial Drug Sales by Region (2022-2027) & (MT) Table 81. Asia Pacific Anti-Malarial Drug Revenue by Region (2016-2021) & (US$ Million) Table 82. Asia Pacific Anti-Malarial Drug Revenue by Region (2022-2027) & (US$ Million) Table 83. Latin America Anti-Malarial Drug Sales by Type (2016-2021) & (MT) Table 84. Latin America Anti-Malarial Drug Sales by Type (2022-2027) & (MT) Table 85. Latin America Anti-Malarial Drug Revenue by Type (2016-2021) & (US$ Million) Table 86. Latin America Anti-Malarial Drug Revenue by Type (2022-2027) & (US$ Million) Table 87. Latin America Anti-Malarial Drug Sales by Application (2016-2021) & (MT) Table 88. Latin America Anti-Malarial Drug Sales by Application (2022-2027) & (MT) Table 89. Latin America Anti-Malarial Drug Revenue by Application (2016-2021) & (US$ Million) Table 90. Latin America Anti-Malarial Drug Revenue by Application (2022-2027) & (US$ Million) Table 91. Latin America Anti-Malarial Drug Sales by Country (2016-2021) & (MT) Table 92. Latin America Anti-Malarial Drug Sales by Country (2022-2027) & (MT) Table 93. Latin America Anti-Malarial Drug Revenue by Country (2016-2021) & (US$ Million) Table 94. Latin America Anti-Malarial Drug Revenue by Country (2022-2027) & (US$ Million) Table 95. Middle East and Africa Anti-Malarial Drug Sales by Type (2016-2021) & (MT) Table 96. Middle East and Africa Anti-Malarial Drug Sales by Type (2022-2027) & (MT) Table 97. Middle East and Africa Anti-Malarial Drug Revenue by Type (2016-2021) & (US$ Million) Table 98. Middle East and Africa Anti-Malarial Drug Revenue by Type (2022-2027) & (US$ Million) Table 99. Middle East and Africa Anti-Malarial Drug Sales by Application (2016-2021) & (MT) Table 100. Middle East and Africa Anti-Malarial Drug Sales by Application (2022-2027) & (MT) Table 101. Middle East and Africa Anti-Malarial Drug Revenue by Application (2016-2021) & (US$ Million) Table 102. Middle East and Africa Anti-Malarial Drug Revenue by Application (2022-2027) & (US$ Million) Table 103. Middle East and Africa Anti-Malarial Drug Sales by Country (2016-2021) & (MT) Table 104. Middle East and Africa Anti-Malarial Drug Sales by Country (2022-2027) & (MT) Table 105. Middle East and Africa Anti-Malarial Drug Revenue by Country (2016-2021) & (US$ Million) Table 106. Middle East and Africa Anti-Malarial Drug Revenue by Country (2022-2027) & (US$ Million) Table 107. GlaxoSmithKline Corporation Information Table 108. GlaxoSmithKline Description and Major Businesses Table 109. GlaxoSmithKline Anti-Malarial Drug Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021) Table 110. GlaxoSmithKline Anti-Malarial Drug Product Table 111. GlaxoSmithKline Recent Developments Table 112. Ranbaxy Corporation Information Table 113. Ranbaxy Description and Major Businesses Table 114. Ranbaxy Anti-Malarial Drug Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021) Table 115. Ranbaxy Anti-Malarial Drug Product Table 116. Ranbaxy Recent Developments Table 117. Zydus Cadila Corporation Information Table 118. Zydus Cadila Description and Major Businesses Table 119. Zydus Cadila Anti-Malarial Drug Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021) Table 120. Zydus Cadila Anti-Malarial Drug Product Table 121. Zydus Cadila Recent Developments Table 122. Alvizia Corporation Information Table 123. Alvizia Description and Major Businesses Table 124. Alvizia Anti-Malarial Drug Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021) Table 125. Alvizia Anti-Malarial Drug Product Table 126. Alvizia Recent Developments Table 127. Bayer Corporation Information Table 128. Bayer Description and Major Businesses Table 129. Bayer Anti-Malarial Drug Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021) Table 130. Bayer Anti-Malarial Drug Product Table 131. Bayer Recent Developments Table 132. Ipca Corporation Information Table 133. Ipca Description and Major Businesses Table 134. Ipca Anti-Malarial Drug Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021) Table 135. Ipca Anti-Malarial Drug Product Table 136. Ipca Recent Developments Table 137. Merck Corporation Information Table 138. Merck Description and Major Businesses Table 139. Merck Anti-Malarial Drug Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021) Table 140. Merck Anti-Malarial Drug Product Table 141. Merck Recent Developments Table 142. F. Hoffmann-La Roche Corporation Information Table 143. F. Hoffmann-La Roche Description and Major Businesses Table 144. F. Hoffmann-La Roche Anti-Malarial Drug Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021) Table 145. F. Hoffmann-La Roche Anti-Malarial Drug Product Table 146. F. Hoffmann-La Roche Recent Developments Table 147. Novartis Corporation Information Table 148. Novartis Description and Major Businesses Table 149. Novartis Anti-Malarial Drug Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021) Table 150. Novartis Anti-Malarial Drug Product Table 151. Novartis Recent Developments Table 152. Pfizer Corporation Information Table 153. Pfizer Description and Major Businesses Table 154. Pfizer Anti-Malarial Drug Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021) Table 155. Pfizer Anti-Malarial Drug Product Table 156. Pfizer Recent Developments Table 157. Key Raw Materials Lists Table 158. Raw Materials Key Suppliers Lists Table 159. Anti-Malarial Drug Distributors List Table 160. Anti-Malarial Drug Customers List Table 161. Anti-Malarial Drug Market Trends Table 162. Anti-Malarial Drug Market Drivers Table 163. Anti-Malarial Drug Market Challenges Table 164. Anti-Malarial Drug Market Restraints Table 165. Research Programs/Design for This Report Table 166. Key Data Information from Secondary Sources Table 167. Key Data Information from Primary Sources List of Figures Figure 1. Anti-Malarial Drug Product Picture Figure 2. Global Anti-Malarial Drug Market Share by Type in 2020 & 2027 Figure 3. Plasmodium Falciparum Product Picture Figure 4. Plasmodium Vivax Product Picture Figure 5. Plasmodium Malariae Product Picture Figure 6. Plasmodium Ovale Product Picture Figure 7. Global Anti-Malarial Drug Sales Market Share by Application in 2020 & 2027 Figure 8. Hospital Pharmacy Figure 9. Retail Pharmacy Figure 10. E-Commerce Figure 11. Others Figure 12. Anti-Malarial Drug Report Years Considered Figure 13. Global Anti-Malarial Drug Sales 2016-2027 (MT) Figure 14. Global Anti-Malarial Drug Revenue, (US$ Million), 2016 VS 2021 VS 2027 Figure 15. Global Anti-Malarial Drug Revenue 2016-2027 (US$ Million) Figure 16. Global Anti-Malarial Drug Revenue Market Share by Region in Percentage: 2020 Versus 2027 Figure 17. Global Anti-Malarial Drug Sales Market Share by Region (2016-2021) Figure 18. Global Anti-Malarial Drug Sales Market Share by Region (2022-2027) Figure 19. North America Anti-Malarial Drug Sales YoY (2016-2027) & (MT) Figure 20. North America Anti-Malarial Drug Revenue YoY (2016-2027) & (US$ Million) Figure 21. Europe Anti-Malarial Drug Sales YoY (2016-2027) & (MT) Figure 22. Europe Anti-Malarial Drug Revenue YoY (2016-2027) & (US$ Million) Figure 23. Asia-Pacific Anti-Malarial Drug Sales YoY (2016-2027) & (MT) Figure 24. Asia-Pacific Anti-Malarial Drug Revenue YoY (2016-2027) & (US$ Million) Figure 25. Latin America Anti-Malarial Drug Sales YoY (2016-2027) & (MT) Figure 26. Latin America Anti-Malarial Drug Revenue YoY (2016-2027) & (US$ Million) Figure 27. Middle East & Africa Anti-Malarial Drug Sales YoY (2016-2027) & (MT) Figure 28. Middle East & Africa Anti-Malarial Drug Revenue YoY (2016-2027) & (US$ Million) Figure 29. The Top 10 and Top 5 Players Market Share by Anti-Malarial Drug Sales in 2020 Figure 30. The Top 10 and Top 5 Players Market Share by Anti-Malarial Drug Revenue in 2020 Figure 31. Anti-Malarial Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020 Figure 32. Global Anti-Malarial Drug Sales Market Share by Type (2016-2027) Figure 33. Global Anti-Malarial Drug Revenue Market Share by Type (2016-2027) Figure 34. Global Anti-Malarial Drug Sales Market Share by Application (2016-2027) Figure 35. Global Anti-Malarial Drug Revenue Market Share by Application (2016-2027) Figure 36. North America Anti-Malarial Drug Sales Market Share by Type (2016-2027) Figure 37. North America Anti-Malarial Drug Revenue Market Share by Type (2016-2027) Figure 38. North America Anti-Malarial Drug Sales Market Share by Application (2016-2027) Figure 39. North America Anti-Malarial Drug Revenue Market Share by Application (2016-2027) Figure 40. North America Anti-Malarial Drug Sales Share by Country (2016-2027) Figure 41. North America Anti-Malarial Drug Revenue Share by Country (2016-2027) Figure 42. U.S. Anti-Malarial Drug Revenue (2016-2027) & (US$ Million) Figure 43. Canada Anti-Malarial Drug Revenue (2016-2027) & (US$ Million) Figure 44. Europe Anti-Malarial Drug Sales Market Share by Type (2016-2027) Figure 45. Europe Anti-Malarial Drug Revenue Market Share by Type (2016-2027) Figure 46. Europe Anti-Malarial Drug Sales Market Share by Application (2016-2027) Figure 47. Europe Anti-Malarial Drug Revenue Market Share by Application (2016-2027) Figure 48. Europe Anti-Malarial Drug Sales Share by Country (2016-2027) Figure 49. Europe Anti-Malarial Drug Revenue Share by Country (2016-2027) Figure 50. Germany Anti-Malarial Drug Revenue (2016-2027) & (US$ Million) Figure 51. France Anti-Malarial Drug Revenue (2016-2027) & (US$ Million) Figure 52. U.K. Anti-Malarial Drug Revenue (2016-2027) & (US$ Million) Figure 53. Italy Anti-Malarial Drug Revenue (2016-2027) & (US$ Million) Figure 54. Russia Anti-Malarial Drug Revenue (2016-2027) & (US$ Million) Figure 55. Asia Pacific Anti-Malarial Drug Sales Market Share by Type (2016-2027) Figure 56. Asia Pacific Anti-Malarial Drug Revenue Market Share by Type (2016-2027) Figure 57. Asia Pacific Anti-Malarial Drug Sales Market Share by Application (2016-2027) Figure 58. Asia Pacific Anti-Malarial Drug Revenue Market Share by Application (2016-2027) Figure 59. Asia Pacific Anti-Malarial Drug Sales Share by Region (2016-2027) Figure 60. Asia Pacific Anti-Malarial Drug Revenue Share by Region (2016-2027) Figure 61. China Anti-Malarial Drug Revenue (2016-2027) & (US$ Million) Figure 62. Japan Anti-Malarial Drug Revenue (2016-2027) & (US$ Million) Figure 63. South Korea Anti-Malarial Drug Revenue (2016-2027) & (US$ Million) Figure 64. India Anti-Malarial Drug Revenue (2016-2027) & (US$ Million) Figure 65. Australia Anti-Malarial Drug Revenue (2016-2027) & (US$ Million) Figure 66. Taiwan Anti-Malarial Drug Revenue (2016-2027) & (US$ Million) Figure 67. Indonesia Anti-Malarial Drug Revenue (2016-2027) & (US$ Million) Figure 68. Thailand Anti-Malarial Drug Revenue (2016-2027) & (US$ Million) Figure 69. Malaysia Anti-Malarial Drug Revenue (2016-2027) & (US$ Million) Figure 70. Philippines Anti-Malarial Drug Revenue (2016-2027) & (US$ Million) Figure 71. Latin America Anti-Malarial Drug Sales Market Share by Type (2016-2027) Figure 72. Latin America Anti-Malarial Drug Revenue Market Share by Type (2016-2027) Figure 73. Latin America Anti-Malarial Drug Sales Market Share by Application (2016-2027) Figure 74. Latin America Anti-Malarial Drug Revenue Market Share by Application (2016-2027) Figure 75. Latin America Anti-Malarial Drug Sales Share by Country (2016-2027) Figure 76. Latin America Anti-Malarial Drug Revenue Share by Country (2016-2027) Figure 77. Mexico Anti-Malarial Drug Revenue (2016-2027) & (US$ Million) Figure 78. Brazil Anti-Malarial Drug Revenue (2016-2027) & (US$ Million) Figure 79. Argentina Anti-Malarial Drug Revenue (2016-2027) & (US$ Million) Figure 80. Middle East and Africa Anti-Malarial Drug Sales Market Share by Type (2016-2027) Figure 81. Middle East and Africa Anti-Malarial Drug Revenue Market Share by Type (2016-2027) Figure 82. Middle East and Africa Anti-Malarial Drug Sales Market Share by Application (2016-2027) Figure 83. Middle East and Africa Anti-Malarial Drug Revenue Market Share by Application (2016-2027) Figure 84. Middle East and Africa Anti-Malarial Drug Sales Share by Country (2016-2027) Figure 85. Middle East and Africa Anti-Malarial Drug Revenue Share by Country (2016-2027) Figure 86. Turkey Anti-Malarial Drug Revenue (2016-2027) & (US$ Million) Figure 87. Saudi Arabia Anti-Malarial Drug Revenue (2016-2027) & (US$ Million) Figure 88. U.A.E Anti-Malarial Drug Revenue (2016-2027) & (US$ Million) Figure 89. Anti-Malarial Drug Value Chain Figure 90. Anti-Malarial Drug Production Process Figure 91. Channels of Distribution Figure 92. Distributors Profiles Figure 93. Bottom-up and Top-down Approaches for This Report Figure 94. Data Triangulation Figure 95. Key Executives Interviewed

GlaxoSmithKline Ranbaxy Zydus Cadila Alvizia Bayer Ipca Merck F. Hoffmann-La Roche Novartis Pfizer